• Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About
Search
Medicines Law & Policy Research and resources on intellectual property and health
  • Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About

Kaitlin Mara

11 POSTS 0 COMMENTS

With technology transfer, 120 companies in low- and middle-income countries could manufacture mRNA vaccines

Kaitlin Mara - February 15, 2022

Landmark decision by the World Health Assembly to start negotiations for a pandemic treaty

Kaitlin Mara - December 1, 2021

The WHO Covid-19 Technology Access Pool signs first licence agreement; will hopefully be a...

Kaitlin Mara - November 23, 2021

WHO’s Essential Medicines Committee takes aim at rising prices, adds new treatments for cancer...

Kaitlin Mara - October 6, 2021

Independent Panel for Pandemic Preparedness and Response: Uneven access to vaccination is pre-eminent problem

Kaitlin Mara - May 12, 2021

Decision on intellectual property waiver over Covid technology on hold till 2021; what are...

Kaitlin Mara - December 18, 2020

Ellen ‘t Hoen named one of the “50 Most Influential People in IP”

Kaitlin Mara - December 2, 2020

Human Rights Watch: All governments should endorse the WHO C-TAP Solidarity Call to Action

Kaitlin Mara - October 30, 2020

Invitation: 14 May 2020 – The WHO Covid-19 Technology Pool: The solution to ensure...

Kaitlin Mara - May 12, 2020

Medicines Law & Policy’s director, Ellen ’t Hoen, receives high Netherlands honour for her...

Kaitlin Mara - April 24, 2020
12Page 1 of 2
Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.
  • Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About
 This work is licensed under Creative Commons.